Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver

Not Applicable

Completed

• Conditions: Fatty Liver

• Registration Number: NCT04281121
• Lead Sponsor: Ain Shams University

Brief Summary

this is a prospective, interventional, open-label, randomized study on the efficacy of omega 3 fatty acids supplementation in Egyptian children with non-alcoholic fatty liver disease who had been selected from nutrition and outpatient clinic at Pediatric hospital, Ain Shams University

Detailed Description

Not available

Study Timeline

• Study Start: 2019-03-01
• Primary Completion: 2020-01-25
• Status Verified: 2020-02
• Study Completion: 2020-02-19
• Study First Submitted: 2020-02-20
• Study First Submitted QC: 2020-02-20
• Last Update Submitted: 2020-02-20
• Study First Posted: 2020-02-24
• Last Update Posted: 2020-02-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Children between 5 - 16 years old with diffusely hyper echogenic liver at ultrasonography were included in the study.

Exclusion Criteria

• Patients with secondary causes of steatosis including total parenteral nutrition, drugs causing fatty liver disease for example steroids, hepatitis A, B, C, cytomegalovirus, Epstein-Barr virus infections, autoimmune liver disease, metabolic liver diseases, Wilson's disease, and alpha-1-antitrypsin deficiency.
• Patients currently taking fish oil supplements.
• Patients with systemic illness such as cardiac and kidney diseases.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
grade of fatty liver in children	3 month	improvement

Trial Locations

Locations (1)

Pediatrics hospital Ain shams University; 🇪🇬 Cairo, Egypt